Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

26–50 of 140 articles for PD-L1 Expression

Then save them, add them to a collection or cite them together.
  1. Research article · 2019

    Comparison of Clinic-Pathological, Molecular Features and PD-L1 Status in a Series of Non-small Cell Lung Cancers: Are Real Life Data Similar to Clinical Trials results?

    Journal of Cytology & Histology · Volume 10, Issue 3

    Selection of patients who are likely to respond to immunotherapy is based on PD-L1 expression, a specific biomarker. Clinic-pathological correlation of PD-L1 status and NSCLC has been ... looked at a series of lung…

  2. Research article · 12 Aug 2019

    IL-10 restores MHC class I expression and interferes tumor immunity in papillary thyroid cancer with concomitant Hashimotos thyroiditis

    Diagnostic Pathology: Open Access · Volume 4, Issue 2

    blood lymphocytes (PBLs) with IL-10 pretreated PTC cells. Programmed death-ligand 1 (PD-L1) expression was measured in PTC tissues and IL-10 pretreated cells ... production along with decreased IFN-γ secretion and PD-1…

  3. Mini review · 31 Aug 2022

    Research on Anti-Cancer Therapies

    Translational Biomedicine · Volume 13, Issue 8

    from anti-PD-1/anti-PD-L1. Patients with tumours that do not express PD-L1 can still benefit from treatment, nevertheless. To increase the response rates to PD ... causes immunogenic alterations in cancer cells, has the…

  4. Research article · 1 Oct 2021

    A high CD8 to FOXP3 Ratio in The Tumor Stroma is Associated with Improved Survival in Non-Metastatic Triple-Negative Breast Carcinoma

    Journal of Clinical Oncology and Cancer Research · Volume 4, Issue 4

    constructed using two cores from each tumor block. The expression of CD4, CD8, FOXP3, CD20, CD68, CD163, PD-1, PD-L1, PTEN and phosphoSTAT1 was determined by immunohistochemistry. Results ... lymphocytes (CD4+ , CD8+…

  5. Conference abstract · 26 May 2017

    CTC immune escape mediated by PD-L1

    Breast Cancer: Current Research

    found to be related with histological grading of tumor. Meanwhile, the high expression of PD-L1 in CTC surface has also been reported. Since PDL1 can mediate Treg to play ... cancer patients. We have also analyzed the…

  6. Editorial · 3 Sep 2018

    Stem Cell Research 2017 : Nano-diamino-tetrac (NDAT; Nanotetrac) acts at its target on integrin αvβ3 in human glioblastoma xenografts to induce necrosis via. anti-angiogenesis and apoptosis_ Paul J Davis_ Albany College of Pharmacy and Health Sciences, USA

    Journal of Cell and Developmental Biology · Volume 2, Issue 3

    described about thyroid hormone-tetrac receptor on integrin α vβ3. NDAT inhibits PD-L1 inducible expression and protein accumulation by inhibition of activated ERK1/2 and PI3K. Knockdown PD-L1 ... oral cancer cells…

  7. Research article · 5 Nov 2025

    Targeting the TLK1-Nek1-mediated activation of YAP1 attenuates PD-L1 and anti-inflammation set for prostate cancer immunoevasion.

    Journal of Clinical and Cellular Immunology · Volume 16, Issue 6

    ARSI have revealed the outlines of an innate immunity integration response that includes PD-L1 expression and alterations in cGAS-pSTING and pSTAT1/3, which drive the immunoevasion ... 10XG) of PEFF prostate sections…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels